Robert Y. Zhao

614 total citations
8 papers, 452 citations indexed

About

Robert Y. Zhao is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Robert Y. Zhao has authored 8 papers receiving a total of 452 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in Molecular Biology. Recurrent topics in Robert Y. Zhao's work include HER2/EGFR in Cancer Research (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Cancer Treatment and Pharmacology (2 papers). Robert Y. Zhao is often cited by papers focused on HER2/EGFR in Cancer Research (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Cancer Treatment and Pharmacology (2 papers). Robert Y. Zhao collaborates with scholars based in China and United States. Robert Y. Zhao's co-authors include Barbara A. Leece, Ravi Chari, Victor S. Goldmacher, Wayne C. Widdison, Yelena Kovtun, Sharon Wilhelm, John M. Lambert, Kathleen R. Whiteman, Walter A. Blättler and Rita M. Steeves and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Robert Y. Zhao

8 papers receiving 428 citations

Peers

Robert Y. Zhao
Heidi L. Perez United States
Patrick Dennler Switzerland
Gemma Mudd United Kingdom
Nicola Ashman United Kingdom
Ravindra A. De Silva United States
Katerine Van Rietschoten United Kingdom
Kelly M. Flagella United States
Punit Upadhyaya United States
Paul Hoppenz Germany
Ola Åberg Sweden
Heidi L. Perez United States
Robert Y. Zhao
Citations per year, relative to Robert Y. Zhao Robert Y. Zhao (= 1×) peers Heidi L. Perez

Countries citing papers authored by Robert Y. Zhao

Since Specialization
Citations

This map shows the geographic impact of Robert Y. Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Y. Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Y. Zhao more than expected).

Fields of papers citing papers by Robert Y. Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Y. Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Y. Zhao. The network helps show where Robert Y. Zhao may publish in the future.

Co-authorship network of co-authors of Robert Y. Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Y. Zhao. A scholar is included among the top collaborators of Robert Y. Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Y. Zhao. Robert Y. Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Yu, Jiaojiao, Huihui� Guo, Yuanyuan Huang, et al.. (2025). The anti-STEAP1/PSMA ADC, DXC008: Assessment of anti-tumor efficacy, pharmacokinetic, and toxicity properties.. Journal of Clinical Oncology. 43(16_suppl). 1 indexed citations
2.
Guo, Huihui, Hongsheng Xie, Yuanyuan Huang, et al.. (2025). The development and evaluation of a tublysine-based antibody-drug conjugate with enhanced tumor therapeutic efficacy. Frontiers in Pharmacology. 16. 1532104–1532104. 1 indexed citations
3.
Yang, Qingliang, Yuanyuan Huang, Huihui� Guo, et al.. (2024). Abstract 5821: DXC008, a novel STEAP1 antibody-tubulysin analog conjugate with a function linker, demonstrates a potential to broaden therapeutic opportunities for prostate tumors. Cancer Research. 84(6_Supplement). 5821–5821. 2 indexed citations
4.
Zhou, Xiaomai, Hongsheng Xie, Huihui Guo, et al.. (2015). Abstract 4532: Functional evaluation of novel Tubulysin analogs as payloads for antibody-drug conjugates. Cancer Research. 75(15_Supplement). 4532–4532. 1 indexed citations
5.
Zhao, Robert Y., Sharon Wilhelm, Charlene A. Audette, et al.. (2011). Synthesis and Evaluation of Hydrophilic Linkers for Antibody–Maytansinoid Conjugates. Journal of Medicinal Chemistry. 54(10). 3606–3623. 150 indexed citations
6.
Zhao, Robert Y., Hans K. Erickson, Barbara A. Leece, et al.. (2011). Synthesis and Biological Evaluation of Antibody Conjugates of Phosphate Prodrugs of Cytotoxic DNA Alkylators for the Targeted Treatment of Cancer. Journal of Medicinal Chemistry. 55(2). 766–782. 47 indexed citations
7.
Widdison, Wayne C., Sharon Wilhelm, Kathleen R. Whiteman, et al.. (2006). Semisynthetic Maytansine Analogues for the Targeted Treatment of Cancer. Journal of Medicinal Chemistry. 49(14). 4392–4408. 231 indexed citations
8.
Miller, Michael L., Robert Y. Zhao, Barbara A. Leece, et al.. (2004). Synthesis of Taxoids with Improved Cytotoxicity and Solubility for Use in Tumor-Specific Delivery. Journal of Medicinal Chemistry. 47(20). 4802–4805. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Heidi L. Perez Breakdown of academic impact, for papers by Patrick Dennler Breakdown of academic impact, for papers by Gemma Mudd Breakdown of academic impact, for papers by Nicola Ashman Breakdown of academic impact, for papers by Ravindra A. De Silva Breakdown of academic impact, for papers by Katerine Van Rietschoten Breakdown of academic impact, for papers by Kelly M. Flagella Breakdown of academic impact, for papers by Punit Upadhyaya Breakdown of academic impact, for papers by Paul Hoppenz Breakdown of academic impact, for papers by Ola Åberg
Rankless by CCL
2026